Potential of Favipiravir and Minocycline Combination Therapy for COVID-19

MLA

Kazuhiro Itoh, et al. “Potential of Favipiravir and Minocycline Combination Therapy for COVID-19.” Re:GEN Open, vol. 2, no. 1, Jan. 2022, pp. 1–3. EBSCOhost, https://doi.org/10.1089/REGEN.2021.0037.

APA

Kazuhiro Itoh, Hiroshi Tsutani, & Hiromichi Iwasaki. (2022). Potential of Favipiravir and Minocycline Combination Therapy for COVID-19. Re:GEN Open, 2(1), 1–3. https://doi.org/10.1089/REGEN.2021.0037

Chicago

Kazuhiro Itoh, Hiroshi Tsutani, and Hiromichi Iwasaki. 2022. “Potential of Favipiravir and Minocycline Combination Therapy for COVID-19.” Re:GEN Open 2 (1): 1–3. doi:10.1089/REGEN.2021.0037.